576P Safety and efficacy of IBI354 (anti-HER2 ADC) in patients (pts) with advanced gastrointestinal (GI) cancers: Results from a phase I study.
Saved in:
| Title: | 576P Safety and efficacy of IBI354 (anti-HER2 ADC) in patients (pts) with advanced gastrointestinal (GI) cancers: Results from a phase I study. |
|---|---|
| Authors: | Gong, J.1 (AUTHOR), Lemech, C.2 (AUTHOR), Day, D.3 (AUTHOR), Shan, J.4 (AUTHOR), Morris, M.5 (AUTHOR), Nagrial, A.6 (AUTHOR), Chen, M.7 (AUTHOR), Huang, X.8 (AUTHOR), Zong, H.9 (AUTHOR), Wang, N.10 (AUTHOR), Yang, Y.11 (AUTHOR), Yi, T.12 (AUTHOR), Li, W.13 (AUTHOR), Zhuang, Z.14 (AUTHOR), Li, Z.15 (AUTHOR), Liu, Z.16 (AUTHOR), Luo, Y.17 (AUTHOR), Zhang, Y.17 (AUTHOR), Zhou, H.17 (AUTHOR), Shen, L.1 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS467-S468. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 179692043 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 576P Safety and efficacy of IBI354 (anti-HER2 ADC) in patients (pts) with advanced gastrointestinal (GI) cancers: Results from a phase I study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Gong%2C+J%2E%22">Gong, J.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lemech%2C+C%2E%22">Lemech, C.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Day%2C+D%2E%22">Day, D.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shan%2C+J%2E%22">Shan, J.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Morris%2C+M%2E%22">Morris, M.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nagrial%2C+A%2E%22">Nagrial, A.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+M%2E%22">Chen, M.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+X%2E%22">Huang, X.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zong%2C+H%2E%22">Zong, H.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+N%2E%22">Wang, N.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yang%2C+Y%2E%22">Yang, Y.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yi%2C+T%2E%22">Yi, T.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+W%2E%22">Li, W.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhuang%2C+Z%2E%22">Zhuang, Z.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Z%2E%22">Li, Z.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Z%2E%22">Liu, Z.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Luo%2C+Y%2E%22">Luo, Y.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Y%2E%22">Zhang, Y.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+H%2E%22">Zhou, H.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shen%2C+L%2E%22">Shen, L.</searchLink><relatesTo>1</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2024 Supplement 2, Vol. 35, pS467-S468. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179692043 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2024.08.645 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S467 Titles: – TitleFull: 576P Safety and efficacy of IBI354 (anti-HER2 ADC) in patients (pts) with advanced gastrointestinal (GI) cancers: Results from a phase I study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gong, J. – PersonEntity: Name: NameFull: Lemech, C. – PersonEntity: Name: NameFull: Day, D. – PersonEntity: Name: NameFull: Shan, J. – PersonEntity: Name: NameFull: Morris, M. – PersonEntity: Name: NameFull: Nagrial, A. – PersonEntity: Name: NameFull: Chen, M. – PersonEntity: Name: NameFull: Huang, X. – PersonEntity: Name: NameFull: Zong, H. – PersonEntity: Name: NameFull: Wang, N. – PersonEntity: Name: NameFull: Yang, Y. – PersonEntity: Name: NameFull: Yi, T. – PersonEntity: Name: NameFull: Li, W. – PersonEntity: Name: NameFull: Zhuang, Z. – PersonEntity: Name: NameFull: Li, Z. – PersonEntity: Name: NameFull: Liu, Z. – PersonEntity: Name: NameFull: Luo, Y. – PersonEntity: Name: NameFull: Zhang, Y. – PersonEntity: Name: NameFull: Zhou, H. – PersonEntity: Name: NameFull: Shen, L. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2024 Supplement 2 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 35 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |